Assessing the Effect of Patient Characteristics on Treatment Response in Primary Hyperhidrosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03694093|
Recruitment Status : Recruiting
First Posted : October 3, 2018
Last Update Posted : October 4, 2018
|Condition or disease|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Official Title:||A Prospective Study Assessing the Effect of Patient Characteristics on Treatment Response in Hyperhidrosis|
|Actual Study Start Date :||August 20, 2018|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||December 2020|
Patients with Hyperhidrosis
Subjects with Primary Hyperhidrosis will be followed in this study. Because this study is observational, there will be no intervention.
- Weeks till treatment response [ Time Frame: 18 months ]We will measure the weeks required to reach treatment response defined as HDSS of 1 or 2.
- Number of treatment changes [ Time Frame: 18 months ]We will quantify the number of failed treatment prior to treatment response.
- Number of treatments at the time of treatment response. [ Time Frame: 18 months ]We will quantify the number of treatments a subject is currently using at the time of treatment response.
- Percent reduction in gravimetric sweat measurements [ Time Frame: 18 months ]We will quantify the percent reduction in gravimetric sweat measurements from initial visit compared to after treatment response is achieved.
- Disease impact [ Time Frame: 18 months ]We will track the disease impact through questionnaire responses throughout the study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03694093
|Contact: Mitchell S Gibbons, BAemail@example.com|
|United States, Missouri|
|Saint Louis University||Recruiting|
|Saint Louis, Missouri, United States, 63131|
|Contact: Mitchell Gibbons, BA|
|Principal Investigator:||Dee A Glaser, MD||St. Louis University|